AGN), is stuck in a trading range for now. The company’s falling revenue but …
Evolus’ $EOLS attempt to field a rival to Allergan’s Botox has run into problems at …
Dublin, Ireland-based Allergan plc (AGN - Free Report) is engaged in the development, manufacturing, marketing, sale and distribution of branded …
From a headline standpoint, Allergan plc (NYSE:AGN) stock does look attractive at the moment. A steady pullback has seen Allergan stock fall about 35% from late July highs and Allergan has dropped by half from 2015 levels. In fact, I …
While 2017 was a great year for many biopharmaceutical companies, for Allergan (NYSE:AGN), it was a different story. Allergan stock plunged last year with its …
In just about two years, Allergan PLC has gone from a pharma darling on the verge of a massively lucrative Pfizer Inc. buyout to something of a pariah. Its stock has …
Shareholders are not very pleased with Allergan plc (NYSE:AGN) after it reported first-quarter results for 2018. The big write-down overshadowed the company’s revenue increase and higher guidance. Allergan stock is worth a second look. …
Shares of Allergan increased almost 4% on Apr 30 in pre-market trading. The stock has lost 3.1% so far this year, outperforming the industry’s decline of 6.1%. …